Viewing Study NCT01983969


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2026-02-25 @ 2:36 AM
Study NCT ID: NCT01983969
Status: COMPLETED
Last Update Posted: 2020-01-27
First Post: 2013-11-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancers View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Cancers View
None Lymphoma View
None Recurrent Hodgkin's View
None non-Hodgkin's lymphoma View
None Stem cell transplant View
None Azacitidine View
None 5-azacytidine View
None 5-aza View
None Vidaza View
None 5-AZC View
None AZA-CR View
None Ladakamycin View
None NSC-102816 View
None Azacytidine View
None Vorinostat View
None SAHA View
None Suberoylanilide Hydroxamic Acid View
None MSK-390 View
None Zolinza View
None Gemcitabine View
None Gemcitabine Hydrochloride View
None Gemzar View
None Busulfan View
None Busulfex View
None Myleran View
None Melphalan View
None Alkeran View
None Dexamethasone View
None Decadron View
None Caphosol View
None Glutamine View
None Enterex View
None Glutapak-10 View
None NutreStore View
None Resource View
None GlutaSolve View
None Sympt-X G.I. View
None Sympt-X View
None Pyridoxine View
None Rituximab View
None Rituxan View